BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khabazian E, Vakhshiteh F, Norouzi P, Fatahi Y, Dinarvand R, Atyabi F. Cationic Liposome Decorated with Cyclic RGD Peptide for Targeted Delivery of anti-STAT3 siRNA to Melanoma Cancer Cells. J Drug Target 2021;:1-34. [PMID: 34482780 DOI: 10.1080/1061186X.2021.1973481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu H, Zhang R, Zhang D, Zhang C, Zhang Z, Fu X, Luo Y, Chen S, Wu A, Zeng W, Qu K, Zhang H, Wang S, Shi H. Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect. IJN 2022;Volume 17:227-44. [DOI: 10.2147/ijn.s341824] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liu P, Ga L, Aodeng G, Wang Y, Ai J. Aptamer-drug conjugates: New probes for imaging and targeted therapy. Biosensors and Bioelectronics: X 2022;10:100126. [DOI: 10.1016/j.biosx.2022.100126] [Reference Citation Analysis]
3 Bergonzini C, Kroese K, Zweemer AJM, Danen EHJ. Targeting Integrins for Cancer Therapy - Disappointments and Opportunities. Front Cell Dev Biol 2022;10:863850. [DOI: 10.3389/fcell.2022.863850] [Cited by in F6Publishing: 1] [Reference Citation Analysis]